Clinical Trial

Optimizing Hamstring Rehabilitation With Amino Acids

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated October 19, 2025 completion). Its status may not reflect the trial's current state.
Summary
Hamstring injuries are among the most prevalent and troublesome injuries in athletes, particularly those engaged in sports that require high-speed movements such as sprinting, kicking, and rapid changes in direction. The hamstring muscles, which include the biceps femoris, semitendinosus, and semimembranosus, are essential for powerful lower limb actions, and thus, any injury to these muscles can significantly impact an athlete's performance and recovery. These injuries often occur during eccentric muscle contractions, such as when the muscles lengthen rapidly under tension, as seen in running and sprinting. According to epidemiological studies, hamstring strains account for a substantial portion of sports-related injuries, with hamstring strains being the most commonly reported injury in disciplines such as football, soccer, rugby, and athletics. In professional football, for instance, hamstring injuries account for approximately 12% of all injuries and represent the most frequent muscle strain, underlining their significance in the context of athletic performance.
Trial Details
NCT Number NCT07086209
Lead Sponsor Universidad de Zaragoza
Conditions Seamless Return to Sports
Enrollment 25 participants
Start Date 2025-09-19
Primary Completion 2025-10-19 (estimated)
Study Completion 2025-10-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-25